US Stock MarketDetailed Quotes

OLMA Olema Pharmaceuticals

Watchlist
  • 6.750
  • +0.030+0.45%
Close Dec 13 16:00 ET
  • 6.770
  • +0.020+0.29%
Post 17:55 ET
498.20MMarket Cap-2.96P/E (TTM)

Olema Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
61.17%37.62M
55.22%33.53M
16.00%34.34M
-1.89%104.96M
11.75%30.42M
0.52%23.34M
-35.12%21.6M
27.30%29.6M
49.65%106.99M
25.10%27.22M
Selling and administrative expenses
13.01%4.4M
22.40%4.42M
-34.24%4.46M
-23.84%18.82M
-19.36%4.54M
-30.49%3.89M
-42.11%3.61M
-6.47%6.78M
21.20%24.71M
-2.54%5.64M
-General and administrative expense
13.01%4.4M
22.40%4.42M
-34.24%4.46M
-23.84%18.82M
-19.36%4.54M
-30.49%3.89M
-42.11%3.61M
-6.47%6.78M
21.20%24.71M
-2.54%5.64M
Research and development costs
70.80%33.23M
61.82%29.11M
30.92%29.88M
4.70%86.14M
19.87%25.87M
10.36%19.45M
-33.51%17.99M
42.58%22.83M
61.01%82.27M
35.11%21.58M
Operating profit
-61.17%-37.62M
-55.22%-33.53M
-16.00%-34.34M
1.89%-104.96M
-11.75%-30.42M
-0.52%-23.34M
35.12%-21.6M
-27.30%-29.6M
-49.65%-106.99M
-25.10%-27.22M
Net non-operating interest income expense
52.58%2.93M
100.52%3.11M
156.86%3.35M
273.65%8.33M
264.95%3.55M
208.52%1.92M
273.49%1.55M
498.62%1.31M
404.07%2.23M
792.66%973K
Non-operating interest income
52.58%2.93M
100.52%3.11M
156.86%3.35M
273.65%8.33M
264.95%3.55M
208.52%1.92M
273.49%1.55M
498.62%1.31M
404.07%2.23M
792.66%973K
Other net income (expense)
274.68%138K
190.91%40K
54.55%17K
29.63%-19K
38.81%93K
34.17%-79K
-320.00%-44K
83.33%11K
42.55%-27K
570.00%67K
Other non- operating income (expenses)
274.68%138K
190.91%40K
54.55%17K
29.63%-19K
38.81%93K
34.17%-79K
-320.00%-44K
83.33%11K
42.55%-27K
570.00%67K
Income before tax
-60.71%-34.56M
-51.19%-30.38M
-9.49%-30.97M
7.76%-96.66M
-2.27%-26.77M
5.36%-21.5M
38.84%-20.1M
-22.82%-28.29M
-47.39%-104.79M
-20.99%-26.18M
Income tax
Net income
-60.71%-34.56M
-51.19%-30.38M
-9.49%-30.97M
7.76%-96.66M
-2.27%-26.77M
5.36%-21.5M
38.84%-20.1M
-22.82%-28.29M
-47.39%-104.79M
-20.99%-26.18M
Net income continuous Operations
-60.71%-34.56M
-51.19%-30.38M
-9.49%-30.97M
7.76%-96.66M
-2.27%-26.77M
5.36%-21.5M
38.84%-20.1M
-22.82%-28.29M
-47.39%-104.79M
-20.99%-26.18M
Minority interest income
Net income attributable to the parent company
-60.71%-34.56M
-51.19%-30.38M
-9.49%-30.97M
7.76%-96.66M
-2.27%-26.77M
5.36%-21.5M
38.84%-20.1M
-22.82%-28.29M
-47.39%-104.79M
-20.99%-26.18M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-60.71%-34.56M
-51.19%-30.38M
-9.49%-30.97M
7.76%-96.66M
-2.27%-26.77M
5.36%-21.5M
38.84%-20.1M
-22.82%-28.29M
-47.39%-104.79M
-20.99%-26.18M
Basic earnings per share
-25.00%-0.6
-10.20%-0.54
20.00%-0.56
18.32%-2.14
26.15%-0.48
15.79%-0.48
40.24%-0.49
-20.69%-0.7
-45.56%-2.62
-20.37%-0.65
Diluted earnings per share
-25.00%-0.6
-10.20%-0.54
20.00%-0.56
18.32%-2.14
26.15%-0.48
15.79%-0.48
40.24%-0.49
-20.69%-0.7
-45.56%-2.62
-20.37%-0.65
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 61.17%37.62M55.22%33.53M16.00%34.34M-1.89%104.96M11.75%30.42M0.52%23.34M-35.12%21.6M27.30%29.6M49.65%106.99M25.10%27.22M
Selling and administrative expenses 13.01%4.4M22.40%4.42M-34.24%4.46M-23.84%18.82M-19.36%4.54M-30.49%3.89M-42.11%3.61M-6.47%6.78M21.20%24.71M-2.54%5.64M
-General and administrative expense 13.01%4.4M22.40%4.42M-34.24%4.46M-23.84%18.82M-19.36%4.54M-30.49%3.89M-42.11%3.61M-6.47%6.78M21.20%24.71M-2.54%5.64M
Research and development costs 70.80%33.23M61.82%29.11M30.92%29.88M4.70%86.14M19.87%25.87M10.36%19.45M-33.51%17.99M42.58%22.83M61.01%82.27M35.11%21.58M
Operating profit -61.17%-37.62M-55.22%-33.53M-16.00%-34.34M1.89%-104.96M-11.75%-30.42M-0.52%-23.34M35.12%-21.6M-27.30%-29.6M-49.65%-106.99M-25.10%-27.22M
Net non-operating interest income expense 52.58%2.93M100.52%3.11M156.86%3.35M273.65%8.33M264.95%3.55M208.52%1.92M273.49%1.55M498.62%1.31M404.07%2.23M792.66%973K
Non-operating interest income 52.58%2.93M100.52%3.11M156.86%3.35M273.65%8.33M264.95%3.55M208.52%1.92M273.49%1.55M498.62%1.31M404.07%2.23M792.66%973K
Other net income (expense) 274.68%138K190.91%40K54.55%17K29.63%-19K38.81%93K34.17%-79K-320.00%-44K83.33%11K42.55%-27K570.00%67K
Other non- operating income (expenses) 274.68%138K190.91%40K54.55%17K29.63%-19K38.81%93K34.17%-79K-320.00%-44K83.33%11K42.55%-27K570.00%67K
Income before tax -60.71%-34.56M-51.19%-30.38M-9.49%-30.97M7.76%-96.66M-2.27%-26.77M5.36%-21.5M38.84%-20.1M-22.82%-28.29M-47.39%-104.79M-20.99%-26.18M
Income tax
Net income -60.71%-34.56M-51.19%-30.38M-9.49%-30.97M7.76%-96.66M-2.27%-26.77M5.36%-21.5M38.84%-20.1M-22.82%-28.29M-47.39%-104.79M-20.99%-26.18M
Net income continuous Operations -60.71%-34.56M-51.19%-30.38M-9.49%-30.97M7.76%-96.66M-2.27%-26.77M5.36%-21.5M38.84%-20.1M-22.82%-28.29M-47.39%-104.79M-20.99%-26.18M
Minority interest income
Net income attributable to the parent company -60.71%-34.56M-51.19%-30.38M-9.49%-30.97M7.76%-96.66M-2.27%-26.77M5.36%-21.5M38.84%-20.1M-22.82%-28.29M-47.39%-104.79M-20.99%-26.18M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -60.71%-34.56M-51.19%-30.38M-9.49%-30.97M7.76%-96.66M-2.27%-26.77M5.36%-21.5M38.84%-20.1M-22.82%-28.29M-47.39%-104.79M-20.99%-26.18M
Basic earnings per share -25.00%-0.6-10.20%-0.5420.00%-0.5618.32%-2.1426.15%-0.4815.79%-0.4840.24%-0.49-20.69%-0.7-45.56%-2.62-20.37%-0.65
Diluted earnings per share -25.00%-0.6-10.20%-0.5420.00%-0.5618.32%-2.1426.15%-0.4815.79%-0.4840.24%-0.49-20.69%-0.7-45.56%-2.62-20.37%-0.65
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data